speb/financial-data huggingface dataset:
Financial ratios for SREI.L — annual report dated 2024-03-31
Total revenue: 10429113.924050633
Net income: 3818987.3417721516
Capital expenditures: 0
Operating cash flow: 30221518.98734177
Net tangible assets: 363734177.2151899
Owner earnings: 3818987.3417721516
Return on net tangible assets (%): 1.0499390986601704
Buffett classification: The Gruesome
Stock price: 0.004556962025316455
P/E ratio: 0.5836254801458401
Shares outstanding: 489110576
Book value: 363734177.2151899
P/B ratio: 0.006127712105794327
Market cap (USD): 2228858.321012658
Debt to equity: 0.6174630241865321
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 61.92499089695352
Free cash flow (dilution-adjusted): 30221518.98734177
Buyback yield (%): 0
Receivables turnover: 0.4153349800877149
Capitalized R&D asset: 0
FCF margin (%): 289.7803131447991
Rule of 40 score: 289.7803131447991
Financial ratios for SREI.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 387632000
Buffett classification: The Gruesome
Stock price: 0.0061333333333333335
Shares outstanding: 489110576
Book value: 387632000
P/B ratio: 0.007738984912150356
Market cap (USD): 2999878.1994666667
Debt to equity: 0.6203890975633246
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SREI.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 391398701.2987013
Buffett classification: The Gruesome
Stock price: 0.005974025974025974
Shares outstanding: 489110576
Book value: 391398701.2987013
P/B ratio: 0.007465429178736267
Market cap (USD): 2921959.285194805
Debt to equity: 0.6042896438679793
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SREI.L — annual report dated 2025-03-31
Total revenue: 47561038.96103896
Net income: 40335064.935064934
Capital expenditures: 0
Operating cash flow: 24128571.42857143
Net tangible assets: 391398701.2987013
Owner earnings: 40335064.935064934
Return on net tangible assets (%): 10.305365041127889
Buffett classification: The Gruesome
Stock price: 0.005974025974025974
P/E ratio: 0.07244216142700753
Shares outstanding: 489110576
Book value: 391398701.2987013
P/B ratio: 0.007465429178736267
Market cap (USD): 2921959.285194805
Debt to equity: 0.6042896438679793
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 14.919993446562177
Free cash flow (dilution-adjusted): 24128571.42857143
Buyback yield (%): 0
Receivables turnover: 1.7062852350556774
Capitalized R&D asset: 0
FCF margin (%): 50.73180055704222
Revenue growth (%): 356.04103385387526
Rule of 40 score: 406.7728344109175
Financial ratios for SREI.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 409321621.6216216
Buffett classification: The Gruesome
Stock price: 0.006486486486486486
Shares outstanding: 489110576
Book value: 409321621.6216216
P/B ratio: 0.007750895564843611
Market cap (USD): 3172609.1416216213
Debt to equity: 0.6107996751381654
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SSNC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 77.01
Shares outstanding: 240834039
Market cap (USD): 18546629343.39
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SSNC — annual report dated 2022-12-31
Total revenue: 5283000000
Gross profit: 2515300000
Operating income: 1142900000
Net income: 650200000
Capital expenditures: 52000000
Operating cash flow: 1134300000
Depreciation & amortization: 671600000
Net tangible assets: -6751700000
Owner earnings: 1269800000
Return on net tangible assets (%): -18.807115245049395
Capex to operating income (%): 4.549829381398197
Buffett classification: The Great
Stock price: 49.55
P/E ratio: 18.353316875499843
Shares outstanding: 240834039
Book value: 6102900000
P/B ratio: 1.9553534602320208
Market cap (USD): 11933326632.449999
Debt to equity: 1.1988726670926937
Current ratio: 1.1066277159028666
Quick ratio: 1.1066277159028666
Effective tax rate (%): 25.921698436251567
Interest coverage ratio: 3.6607943625880845
COGS to revenue (%): 52.38879424569374
R&D to revenue (%): 8.466780238500851
SG&A to revenue (%): 17.51088396744274
Free cash flow (dilution-adjusted): 801200000
Buyback yield (%): 3.989667044773191
Retained earnings: 2740100000
Receivables turnover: 2.9560205908683974
Capitalized R&D asset: 447300000
ROCI (R&D-adjusted, %): 9.66545493567989
FCF margin (%): 15.165625591519968
Rule of 40 score: 15.165625591519968
Financial ratios for SSNC — annual report dated 2023-12-31
Total revenue: 5502800000
Gross profit: 2651800000
Operating income: 1208900000
Net income: 608600000
Capital expenditures: 56500000
Operating cash flow: 1215100000
Depreciation & amortization: 670400000
Net tangible assets: -6211400000
Owner earnings: 1222500000
Return on net tangible assets (%): -19.681553273014135
Capex to operating income (%): 4.67367027876582
Buffett classification: The Great
Stock price: 59.07
P/E ratio: 23.375068491176467
Shares outstanding: 240834039
Book value: 6397700000
P/B ratio: 2.223622033501102
Market cap (USD): 14226066683.73
Debt to equity: 1.0814980383575348
Current ratio: 1.074127097749145
Quick ratio: 1.074127097749145
Effective tax rate (%): 29.04278885391162
Interest coverage ratio: 2.5381062355658197
COGS to revenue (%): 51.809987642654654
R&D to revenue (%): 8.610162099294904
SG&A to revenue (%): 17.611034382496186
Free cash flow (dilution-adjusted): 804100000
Buyback yield (%): 3.315041398894589
Retained earnings: 3126300000
Receivables turnover: 1.5945060995045057
Capitalized R&D asset: 773491000
ROCI (R&D-adjusted, %): 9.10790769644242
Rosenberg metric: 0.3051643192488263
FCF margin (%): 14.612560878098424
Revenue growth (%): 4.160514858981639
Rule of 40 score: 18.773075737080063
Financial ratios for SSNC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 72.53
Shares outstanding: 240834039
Market cap (USD): 17467692848.670002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SSNC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 74.3
Shares outstanding: 240834039
Market cap (USD): 17893969097.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SSNC — annual report dated 2024-12-31
Total revenue: 5882000000
Gross profit: 2863600000
Operating income: 1343500000
Net income: 761700000
Capital expenditures: 56600000
Operating cash flow: 1388600000
Depreciation & amortization: 680100000
Net tangible assets: -6204800000
Owner earnings: 1385200000
Return on net tangible assets (%): -22.324651882413615
Capex to operating income (%): 4.212876814291031
Buffett classification: The Great
Stock price: 74.3
P/E ratio: 23.49214795549429
Shares outstanding: 240834039
Book value: 6609100000
P/B ratio: 2.7074744061521234
Market cap (USD): 17893969097.7
Debt to equity: 1.0870920397633566
Current ratio: 1.116689249707186
Quick ratio: 1.116689249707186
Effective tax rate (%): 14.770057066129574
Interest coverage ratio: 2.9017278617710582
COGS to revenue (%): 51.31587895273716
R&D to revenue (%): 8.80142808568514
SG&A to revenue (%): 17.04182250935056
Free cash flow (dilution-adjusted): 929600000
Buyback yield (%): 4.121500355641022
Retained earnings: 3641900000
Receivables turnover: 1.4305170484945766
Capitalized R&D asset: 982755000
ROCI (R&D-adjusted, %): 8.815072651294523
Rosenberg metric: 0.4470240607851414
FCF margin (%): 15.804148248894933
Revenue growth (%): 6.891037290106855
Rule of 40 score: 22.695185539001788
Financial ratios for SSNC — quarterly report dated 2025-03-31
Total revenue: 1513900000
Gross profit: 747100000
Operating income: 357900000
Net income: 213200000
Capital expenditures: 12700000
Operating cash flow: 272200000
Depreciation & amortization: 170800000
Net tangible assets: -6269300000
Owner earnings: 371300000
Return on net tangible assets (%): -5.922511285151452
Capex to operating income (%): 3.548477228276055
Buffett classification: The Great
Stock price: 82.13
P/E ratio: 23.193831640560504
Shares outstanding: 240834039
Book value: 6859800000
P/B ratio: 2.883422202260999
Market cap (USD): 19779699623.07
Debt to equity: 1.024927840461821
Current ratio: 1.1071124512238382
Quick ratio: 1.1071124512238382
Effective tax rate (%): 18.407960199004975
Interest coverage ratio: 3.4020912547528517
COGS to revenue (%): 50.6506374265143
R&D to revenue (%): 8.527643833806724
SG&A to revenue (%): 17.180791333641587
Free cash flow (dilution-adjusted): 159800000
Buyback yield (%): 1.0460219515097324
Retained earnings: 3791200000
Receivables turnover: 0.2725047250472505
Capitalized R&D asset: 129100000
ROCI (R&D-adjusted, %): 2.9804421768707483
FCF margin (%): 10.555518858577184
Rule of 40 score: 10.555518858577184
Financial ratios for SSNC — quarterly report dated 2025-06-30
Total revenue: 1536800000
Gross profit: 736900000
Operating income: 344500000
Net income: 181100000
Capital expenditures: 22900000
Operating cash flow: 372900000
Depreciation & amortization: 174900000
Net tangible assets: -6216400000
Owner earnings: 333100000
Return on net tangible assets (%): -5.358406794929541
Capex to operating income (%): 6.647314949201742
Buffett classification: The Great
Stock price: 81.67
P/E ratio: 49.88312443603855
Shares outstanding: 240834039
Book value: 7009300000
P/B ratio: 2.806117010989685
Market cap (USD): 19668915965.13
Debt to equity: 1.0011556075499692
Current ratio: 1.136211814613453
Quick ratio: 1.136211814613453
Effective tax rate (%): 24.384133611691023
Interest coverage ratio: 3.265402843601896
COGS to revenue (%): 52.04971369078605
R&D to revenue (%): 8.335502342529931
SG&A to revenue (%): 17.19807391983342
Free cash flow (dilution-adjusted): 237000000
Buyback yield (%): 1.374249605210581
Retained earnings: 3909900000
Receivables turnover: 0.3847386340877228
Capitalized R&D asset: 214597000
ROCI (R&D-adjusted, %): 2.562523554473199
Rosenberg metric: -0.07900852052672347
FCF margin (%): 15.421655387818845
Revenue growth (%): 1.512649448444415
Rule of 40 score: 16.93430483626326
Financial ratios for SSNC — quarterly report dated 2025-09-30
Total revenue: 1568000000
Gross profit: 747800000
Operating income: 365700000
Net income: 210400000
Capital expenditures: 29000000
Operating cash flow: 456200000
Depreciation & amortization: 175400000
Net tangible assets: -6048200000
Owner earnings: 356800000
Return on net tangible assets (%): -5.899275817598625
Capex to operating income (%): 7.929997265518185
Buffett classification: The Great
Stock price: 87.81
P/E ratio: 34.97211338612535
Shares outstanding: 240834039
Book value: 6984500000
P/B ratio: 3.0277953990393014
Market cap (USD): 21147636964.59
Debt to equity: 0.9744147755744864
Current ratio: 1.1163537186614916
Quick ratio: 1.1163537186614916
Effective tax rate (%): 17.132729421031904
Interest coverage ratio: 3.5095969289827256
COGS to revenue (%): 52.308673469387756
R&D to revenue (%): 7.563775510204082
SG&A to revenue (%): 16.804846938775512
Free cash flow (dilution-adjusted): 305800000
Buyback yield (%): 1.1353514362007817
Retained earnings: 4052900000
Receivables turnover: 0.33427846590061183
Capitalized R&D asset: 247030000
ROCI (R&D-adjusted, %): 2.3983634748681744
Rosenberg metric: 0.08508977361436378
FCF margin (%): 19.502551020408163
Revenue growth (%): 2.030192608016658
Rule of 40 score: 21.53274362842482
Financial ratios for SSNC — annual report dated 2025-12-31
Total revenue: 6272200000
Gross profit: 3021600000
Operating income: 1436700000
Net income: 798700000
Capital expenditures: 63000000
Operating cash flow: 1744800000
Depreciation & amortization: 703800000
Net tangible assets: -6846700000
Owner earnings: 1439500000
Return on net tangible assets (%): -21.02472724086056
Capex to operating income (%): 4.38504907078722
Buffett classification: The Great
Stock price: 86.76
P/E ratio: 26.16096309457869
Shares outstanding: 240834039
Book value: 6941800000
P/B ratio: 3.0099918210896313
Market cap (USD): 20894761223.64
Debt to equity: 1.1015298625716672
Current ratio: 1.0736407567546418
Quick ratio: 1.0736407567546418
Effective tax rate (%): 18.0652441526467
Interest coverage ratio: 3.30503795721187
COGS to revenue (%): 51.825515767992094
R&D to revenue (%): 8.091259845030452
SG&A to revenue (%): 17.17738592519371
Free cash flow (dilution-adjusted): 1184400000
Buyback yield (%): 4.95818061241057
Retained earnings: 4179200000
Receivables turnover: 1.2992915441024153
Capitalized R&D asset: 1010713000
ROCI (R&D-adjusted, %): 8.696186302105904
Rosenberg metric: 0.3051960594939154
FCF margin (%): 18.883326424540034
Revenue growth (%): 6.633798027881673
Rule of 40 score: 25.517124452421704
Financial ratios for SSNC — quarterly report dated 2025-12-31
Total revenue: 1653500000
Gross profit: 789800000
Operating income: 368600000
Net income: 194000000
Capital expenditures: 1600000
Operating cash flow: 643500000
Depreciation & amortization: 182700000
Net tangible assets: -6846700000
Owner earnings: 375100000
Return on net tangible assets (%): -5.478551711043276
Capex to operating income (%): 0.4340748779164406
Buffett classification: The Great
Stock price: 86.76
P/E ratio: 26.16096309457869
Shares outstanding: 240834039
Book value: 6941800000
P/B ratio: 3.0099918210896313
Market cap (USD): 20894761223.64
Debt to equity: 1.1015298625716672
Current ratio: 1.0736407567546418
Quick ratio: 1.0736407567546418
Effective tax rate (%): 11.85824625170377
Interest coverage ratio: 3.0767946577629384
COGS to revenue (%): 52.23465376474146
R&D to revenue (%): 7.964922890837617
SG&A to revenue (%): 17.508315693982464
Free cash flow (dilution-adjusted): 481800000
Buyback yield (%): 1.5252627038371125
Retained earnings: 4179200000
Receivables turnover: 0.342523925922857
Capitalized R&D asset: 253435000
ROCI (R&D-adjusted, %): 2.3601019353782013
Rosenberg metric: 0.35413153456998314
FCF margin (%): 29.138191714544902
Revenue growth (%): 5.45280612244898
Rule of 40 score: 34.59099783699388
Financial ratios for SUKHJITS.NS — annual report dated 2023-03-31
Total revenue: 176196382.46041414
Gross profit: 31571108.4043849
Operating income: 13575493.30085262
Net income: 7717807.551766139
Capital expenditures: 4489878.197320341
Operating cash flow: 4990121.802679659
Depreciation & amortization: 4340462.850182705
Net tangible assets: 56698258.22168088
Owner earnings: 7568392.204628502
Return on net tangible assets (%): 13.34854445622885
Capex to operating income (%): 33.07340733642696
Buffett classification: The Good
Stock price: 2.2490864799025583
P/E ratio: 9.104976705721935
Shares outstanding: 31244000
Book value: 56703934.22655298
P/B ratio: 1.2392518955972143
Market cap (USD): 70270457.97807553
Debt to equity: 0.7136869003325822
Current ratio: 1.310879652628029
Quick ratio: 0.6848754518116545
Effective tax rate (%): 26.515082982498868
Interest coverage ratio: 4.004181845616606
COGS to revenue (%): 82.0818634505859
SG&A to revenue (%): 3.324583223389525
Free cash flow (dilution-adjusted): 500243.60535931797
Buyback yield (%): 0
Retained earnings: 674141.2911084044
Inventory turnover: 6.635491900204981
Receivables turnover: 17.92395246455968
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.699594941761458
FCF margin (%): 0.2839125289486049
Rule of 40 score: 0.2839125289486049
Financial ratios for SUKHJITS.NS — annual report dated 2024-03-31
Total revenue: 164929284.08682096
Gross profit: 29160294.999400407
Operating income: 11175104.928648518
Net income: 5991365.871207579
Capital expenditures: 4273186.233361314
Operating cash flow: 9322652.59623456
Depreciation & amortization: 4177083.5831634486
Net tangible assets: 60274397.40976136
Owner earnings: 5895263.221009714
Return on net tangible assets (%): 9.780708682879313
Capex to operating income (%): 38.23844393985569
Buffett classification: The Good
Stock price: 2.709572936660269
P/E ratio: 14.129982820753755
Shares outstanding: 31244000
Book value: 60278102.89003477
P/B ratio: 1.4044552295790511
Market cap (USD): 84657896.83301345
Debt to equity: 0.6729007790767143
Current ratio: 1.3092193100099256
Quick ratio: 0.616620294508032
Effective tax rate (%): 28.49106594581596
Interest coverage ratio: 2.861487347505274
COGS to revenue (%): 82.3195164152595
SG&A to revenue (%): 3.609151825363419
Free cash flow (dilution-adjusted): 4220566.015109725
Buyback yield (%): 0
Retained earnings: 359659.43158652115
Inventory turnover: 4.912212743543753
Receivables turnover: 17.326748302404976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.526890932318366
FCF margin (%): 2.5590155432239454
Revenue growth (%): -6.394625256352553
Rule of 40 score: -3.8356097131286075
Financial ratios for SUKHJITS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 63432871.47634974
Buffett classification: The Gruesome
Stock price: 3.4268991877687527
Shares outstanding: 31244000
Book value: 63435260.39178214
P/B ratio: 1.6878631467952094
Market cap (USD): 107070038.2226469
Debt to equity: 0.6788619417036981
Current ratio: 1.3733396165287308
Quick ratio: 0.5915235767089801
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUKHJITS.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.088355286163888
Shares outstanding: 31244000
Market cap (USD): 96492572.56090452
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUKHJITS.NS — annual report dated 2025-03-31
Total revenue: 175116904.3722235
Gross profit: 46520925.88262801
Operating income: 8860182.370820668
Net income: 4670329.67032967
Capital expenditures: 4657470.189385083
Operating cash flow: 7922609.305588028
Depreciation & amortization: 4196866.962824409
Net tangible assets: 63483458.03133037
Owner earnings: 4209726.443768997
Return on net tangible assets (%): 6.631217917731281
Capex to operating income (%): 52.5663016229054
Buffett classification: The Good
Stock price: 2.261640798226164
P/E ratio: 15.130132150776054
Shares outstanding: 31244000
Book value: 63490577.50759878
P/B ratio: 1.1129636534070133
Market cap (USD): 70662705.09977828
Debt to equity: 0.5498349838629611
Current ratio: 1.4739974345610822
Quick ratio: 0.7153753500567145
Effective tax rate (%): 25.949953660797032
Interest coverage ratio: 2.5196143617021276
COGS to revenue (%): 73.43436029239962
SG&A to revenue (%): 3.4546480189592446
Free cash flow (dilution-adjusted): 3265139.116202946
Buyback yield (%): 0
Retained earnings: 1513946.691606266
Inventory turnover: 4.847424300445915
Receivables turnover: 13.194565560153547
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.369586341206594
FCF margin (%): 1.8645482158950566
Revenue growth (%): 6.176962655121717
Rule of 40 score: 8.041510871016774
Financial ratios for SUKHJITS.NS — quarterly report dated 2025-03-31
Total revenue: 42056347.90741173
Gross profit: 10005845.218611175
Operating income: 849894.7860649987
Net income: 327332.2422258592
Capital expenditures: 0
Depreciation & amortization: 1128127.1919569792
Net tangible assets: 63483458.03133037
Owner earnings: 1455459.4341828385
Return on net tangible assets (%): 2.2926593467301983
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.261640798226164
P/E ratio: 53.96864101995566
Shares outstanding: 31244000
Book value: 63490577.50759878
P/B ratio: 1.1129636534070133
Market cap (USD): 70662705.09977828
Debt to equity: 0.5498349838629611
Current ratio: 1.4739974345610822
Quick ratio: 0.7153753500567145
Effective tax rate (%): 36.36363636363637
Interest coverage ratio: 1.2259696458684652
COGS to revenue (%): 76.20847810979848
Buyback yield (%): 0
Retained earnings: 1513946.691606266
Inventory turnover: 1.2081434225236607
Receivables turnover: 3.1688273709170796
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9946812600682404
Rule of 40 score: 0
Financial ratios for SUKHJITS.NS — quarterly report dated 2025-06-30
Total revenue: 43193306.810203604
Gross profit: 10273812.309852563
Operating income: 1168967.9382167098
Net income: 586239.1762227943
Capital expenditures: 0
Depreciation & amortization: 1058974.9590451673
Owner earnings: 1645214.1352679618
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.1213433185115846
P/E ratio: 72.5496105779289
Shares outstanding: 31244000
Market cap (USD): 66279250.64357595
Effective tax rate (%): 16.777408637873755
Interest coverage ratio: 1.3741403026134802
COGS to revenue (%): 76.21434183079133
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.7034180554500846
Rule of 40 score: 2.7034180554500846
Financial ratios for SUKHJITS.NS — quarterly report dated 2025-09-30
Total revenue: 35468996.61781285
Gross profit: 10042841.037204059
Operating income: 1032694.475760992
Net income: 484780.1578354002
Capital expenditures: 0
Depreciation & amortization: 1020293.122886133
Net tangible assets: 61979706.877113864
Owner earnings: 1505073.280721533
Return on net tangible assets (%): 2.428332363213038
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8749718151071026
P/E ratio: 41.893340977152334
Shares outstanding: 31244000
Book value: 61985343.85569334
P/B ratio: 0.945088237754861
Market cap (USD): 58581619.39120632
Debt to equity: 0.7445663047234501
Current ratio: 1.4171964514491526
Quick ratio: 0.4771205492035098
Effective tax rate (%): 12.423625254582483
Interest coverage ratio: 1.0361990950226243
COGS to revenue (%): 71.68557897078924
Buyback yield (%): 0
Inventory turnover: 0.5799177166366676
Receivables turnover: 3.3763683193818417
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.237603696597941
Revenue growth (%): -17.88311838760637
Rule of 40 score: -17.88311838760637
Financial ratios for SUKHJITS.NS — quarterly report dated 2025-12-31
Total revenue: 38654338.86599087
Gross profit: 10856633.619249193
Operating income: 1167427.8712264677
Net income: 348668.82031859196
Capital expenditures: 0
Depreciation & amortization: 1008131.8926144593
Owner earnings: 1356800.7129330512
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.0689539935390444
P/E ratio: 37.001513376627514
Shares outstanding: 31244000
Market cap (USD): 64642398.5741339
Effective tax rate (%): 25.119617224880386
Interest coverage ratio: 1.3067331670822941
COGS to revenue (%): 71.91354466858789
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 8.980638168316023
Rule of 40 score: 8.980638168316023
Financial ratios for SUMICHEM.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.771198734010286
Shares outstanding: 499145736
Market cap (USD): 2880669239.6898327
Buyback yield (%): 0
Retained earnings: 21521033.891599633
Capitalized R&D asset: 158644.33601476988
Rule of 40 score: 0
Financial ratios for SUMICHEM.NS — annual report dated 2023-03-31
Total revenue: 423062241.16930574
Gross profit: 144683922.04628503
Operating income: 75005115.71254568
Net income: 61170401.948842876
Capital expenditures: 14559805.115712546
Operating cash flow: 47428136.41900122
Depreciation & amortization: 6318879.415347138
Net tangible assets: 287481973.2034105
Owner earnings: 52929476.24847747
Return on net tangible assets (%): 18.4114070383908
Capex to operating income (%): 19.411749421882714
Buffett classification: The Great
Stock price: 5.074908647990256
P/E ratio: 41.410860996995275
Shares outstanding: 499145736
Book value: 290107429.9634592
P/B ratio: 8.731658518890479
Market cap (USD): 2533119012.233861
Debt to equity: 0.01426327010616421
Current ratio: 2.987732020861781
Quick ratio: 2.035214437758709
Effective tax rate (%): 23.23029276524972
Interest coverage ratio: 159.86292834890963
COGS to revenue (%): 65.80079525736171
R&D to revenue (%): 0.032389563823419586
SG&A to revenue (%): 4.0121888406580295
Free cash flow (dilution-adjusted): 32825943.97076736
Buyback yield (%): 0
Retained earnings: 19941656.516443364
Inventory turnover: 2.5717269215491894
Receivables turnover: 3.6713672042635683
Capitalized R&D asset: 243319.7197462174
ROCI (R&D-adjusted, %): 25.274003864053928
FCF margin (%): 7.759128746644802
Rule of 40 score: 7.759128746644802
Financial ratios for SUMICHEM.NS — annual report dated 2024-03-31
Total revenue: 337902266.458808
Gross profit: 122215613.38289963
Operating income: 51261062.47751529
Net income: 44339129.39201343
Capital expenditures: 7423072.310828636
Operating cash flow: 90798896.75020985
Depreciation & amortization: 7457608.825998321
Net tangible assets: 282354598.8727665
Owner earnings: 44373665.90718312
Return on net tangible assets (%): 15.715581075829618
Capex to operating income (%): 14.480917780595416
Buffett classification: The Great
Stock price: 4.145753358925144
P/E ratio: 46.67063020835726
Shares outstanding: 499145736
Book value: 293145700.9233721
P/B ratio: 7.059066890959061
Market cap (USD): 2069335111.615163
Debt to equity: 0.01237409707012602
Current ratio: 3.3381416080619157
Quick ratio: 2.5757965188090965
Effective tax rate (%): 26.48464652409394
Interest coverage ratio: 119.03815093288777
COGS to revenue (%): 63.83107616775979
R&D to revenue (%): 0.0476263651323903
SG&A to revenue (%): 4.302733334587281
Free cash flow (dilution-adjusted): 83154934.64444178
Buyback yield (%): 0
Retained earnings: 27277131.55054563
Inventory turnover: 2.946552492414959
Receivables turnover: 3.935907016634703
Capitalized R&D asset: 305091.9678921038
ROCI (R&D-adjusted, %): 16.998816694021436
Rosenberg metric: -163.96872366790592
FCF margin (%): 24.609167471973375
Revenue growth (%): -20.129419840239883
Rule of 40 score: 4.479747631733492
Financial ratios for SUMICHEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 313815934.06593406
Buffett classification: The Gruesome
Stock price: 6.62123745819398
Shares outstanding: 499145736
Book value: 324500597.2288581
P/B ratio: 10.18476536722716
Market cap (USD): 3304962444.3010035
Debt to equity: 0.010635991429367556
Current ratio: 2.9761248825833477
Quick ratio: 2.436901748421146
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUMICHEM.NS — quarterly report dated 2024-12-31
Total revenue: 74824455.06469285
Gross profit: 31535493.647278234
Operating income: 10147336.519407855
Net income: 10191164.47138361
Capital expenditures: 0
Depreciation & amortization: 2222170.416132416
Owner earnings: 12413334.887516027
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.181839375218557
P/E ratio: 75.69396935555302
Shares outstanding: 499145736
Market cap (USD): 3085638764.7772465
Effective tax rate (%): 24.953433876104068
Interest coverage ratio: 48.71516508114158
COGS to revenue (%): 57.854028311983285
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUMICHEM.NS — annual report dated 2025-03-31
Total revenue: 364623217.20832354
Gross profit: 144459551.08721066
Operating income: 66330722.46902034
Net income: 59205400.98199672
Capital expenditures: 3341828.3843815755
Operating cash flow: 52782791.67640869
Depreciation & amortization: 7722469.02034136
Net tangible assets: 329076338.55506194
Owner earnings: 63586041.617956504
Return on net tangible assets (%): 19.322580862895165
Capex to operating income (%): 5.038130537387666
Buffett classification: The Great
Stock price: 6.498657953086708
P/E ratio: 54.78853876848316
Shares outstanding: 499145736
Book value: 339616553.65910685
P/B ratio: 9.551293575229225
Market cap (USD): 3243777407.005718
Debt to equity: 0.017862847150508763
Current ratio: 3.129271491890615
Quick ratio: 2.40022358570129
Effective tax rate (%): 25.54881768800488
Interest coverage ratio: 120.64490750584733
COGS to revenue (%): 60.381142980076554
R&D to revenue (%): 0.05068953477523312
SG&A to revenue (%): 4.7908824243255905
Free cash flow (dilution-adjusted): 49339373.39256488
Buyback yield (%): 0
Retained earnings: 42332943.65209258
Inventory turnover: 2.6764024153676274
Receivables turnover: 3.9815093289488463
Capitalized R&D asset: 337868.53734235023
ROCI (R&D-adjusted, %): 18.906426637796674
Rosenberg metric: 138.2207127542844
FCF margin (%): 13.531604973024896
Revenue growth (%): 7.907893317659339
Rule of 40 score: 21.439498290684234
Financial ratios for SUMICHEM.NS — quarterly report dated 2025-03-31
Total revenue: 79427285.48047696
Gross profit: 31793079.261164363
Operating income: 12058218.377367312
Net income: 11665302.782324059
Capital expenditures: 0
Depreciation & amortization: 1919102.1744213232
Net tangible assets: 329076338.55506194
Owner earnings: 13584404.956745382
Return on net tangible assets (%): 4.128040629233026
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.498657953086708
P/E ratio: 69.517642780796
Shares outstanding: 499145736
Book value: 339616553.65910685
P/B ratio: 9.551293575229225
Market cap (USD): 3243777407.005718
Debt to equity: 0.017862847150508763
Current ratio: 3.129271491890615
Quick ratio: 2.40022358570129
Effective tax rate (%): 25.033432001562666
Interest coverage ratio: 62.13614457831326
COGS to revenue (%): 59.97209388582338
Buyback yield (%): 0
Retained earnings: 42332943.65209258
Inventory turnover: 0.5790615083115307
Receivables turnover: 0.8673075744732999
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.439059764941235
Revenue growth (%): 6.151505429347292
Rule of 40 score: 6.151505429347292
Financial ratios for SUMICHEM.NS — quarterly report dated 2025-06-30
Total revenue: 123657734.61268431
Gross profit: 47082611.74818629
Operating income: 23808448.39691084
Net income: 20868125.43880178
Capital expenditures: 0
Depreciation & amortization: 1839457.0559326003
Owner earnings: 22707582.49473438
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.169553007254857
P/E ratio: 72.07806751396235
Shares outstanding: 499145736
Market cap (USD): 3079506076.597239
Effective tax rate (%): 25.97592604907894
Interest coverage ratio: 122.49668874172185
COGS to revenue (%): 61.925057178463994
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 55.68671882042234
Rule of 40 score: 55.68671882042234
Financial ratios for SUMICHEM.NS — quarterly report dated 2025-12-31
Total revenue: 63270357.58048346
Gross profit: 29968920.574802272
Operating income: 9217555.976384094
Net income: 8443800.824328842
Capital expenditures: 0
Depreciation & amortization: 1864654.1160744124
Owner earnings: 10308454.940403255
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.234153948980729
P/E ratio: 51.05897304244165
Shares outstanding: 499145736
Market cap (USD): 2612605625.2012925
Effective tax rate (%): 25.374603737176837
Interest coverage ratio: 40.94309747649679
COGS to revenue (%): 52.63355270802742
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -48.834290245849736
Rule of 40 score: -48.834290245849736
Financial ratios for SXC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.34
Shares outstanding: 84853198
Market cap (USD): 453116077.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SXC — annual report dated 2022-12-31
Total revenue: 1972500000
Gross profit: 367600000
Operating income: 153700000
Net income: 104900000
Capital expenditures: 75500000
Operating cash flow: 208900000
Depreciation & amortization: 142500000
Net tangible assets: 552400000
Owner earnings: 171900000
Return on net tangible assets (%): 31.11875452570601
Capex to operating income (%): 49.12166558230319
Buffett classification: The Good
Stock price: 7.25
P/E ratio: 5.864496525262155
Shares outstanding: 84853198
Book value: 622700000
P/B ratio: 0.9879326890958728
Market cap (USD): 615185685.5
Debt to equity: 0.8546651678175686
Current ratio: 1.6696428571428572
Quick ratio: 0.8875
Effective tax rate (%): 13.804437140509448
Interest coverage ratio: 4.803125
COGS to revenue (%): 81.3637515842839
SG&A to revenue (%): 3.619771863117871
Free cash flow (dilution-adjusted): 126700000
Buyback yield (%): 0
Retained earnings: 53500000
Inventory turnover: 9.160388127853881
Receivables turnover: 18.821564885496183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.743743883685166
FCF margin (%): 6.423320659062104
Rule of 40 score: 6.423320659062104
Financial ratios for SXC — annual report dated 2023-12-31
Total revenue: 2063200000
Gross profit: 338600000
Operating income: 125100000
Net income: 63500000
Capital expenditures: 109200000
Operating cash flow: 249000000
Depreciation & amortization: 142800000
Net tangible assets: 583100000
Owner earnings: 97100000
Return on net tangible assets (%): 16.65237523580861
Capex to operating income (%): 87.29016786570743
Buffett classification: The Gruesome
Stock price: 9.41
P/E ratio: 12.574308554015747
Shares outstanding: 84853198
Book value: 645500000
P/B ratio: 1.2369769065530598
Market cap (USD): 798468593.1800001
Debt to equity: 0.763439194422928
Current ratio: 1.8623771224307417
Quick ratio: 1.0464700625558534
Effective tax rate (%): 35.07157464212679
Interest coverage ratio: 4.582417582417582
COGS to revenue (%): 83.58860023264832
SG&A to revenue (%): 3.4267157813105853
Free cash flow (dilution-adjusted): 134700000
Buyback yield (%): 0
Retained earnings: 80200000
Inventory turnover: 9.444687842278205
Receivables turnover: 23.001114827201782
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.708060698872337
FCF margin (%): 6.528693291973633
Revenue growth (%): 4.598225602027883
Rule of 40 score: 11.126918894001516
Financial ratios for SXC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.86
Shares outstanding: 84853198
Market cap (USD): 666946136.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SXC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.78
Shares outstanding: 84853198
Market cap (USD): 829864276.4399999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SXC — annual report dated 2024-12-31
Total revenue: 1935400000
Gross profit: 332000000
Operating income: 151900000
Net income: 103500000
Capital expenditures: 72900000
Operating cash flow: 168800000
Depreciation & amortization: 118900000
Net tangible assets: 651000000
Owner earnings: 149500000
Return on net tangible assets (%): 22.964669738863286
Capex to operating income (%): 47.99210006583278
Buffett classification: The Good
Stock price: 9.78
P/E ratio: 8.018012332753623
Shares outstanding: 84853198
Book value: 711000000
P/B ratio: 1.1671790104641349
Market cap (USD): 829864276.4399999
Debt to equity: 0.6964838255977497
Current ratio: 2.306122448979592
Quick ratio: 1.4275996112730807
Effective tax rate (%): 19.45525291828794
Interest coverage ratio: 6.4914529914529915
COGS to revenue (%): 82.84592332334401
SG&A to revenue (%): 3.1621370259377906
Free cash flow (dilution-adjusted): 91900000
Buyback yield (%): 0
Retained earnings: 138100000
Inventory turnover: 8.868362831858407
Receivables turnover: 20.0351966873706
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.387035010940918
FCF margin (%): 4.748372429471944
Revenue growth (%): -6.194261341605274
Rule of 40 score: -1.4458889121333298
Financial ratios for SXC — quarterly report dated 2025-03-31
Total revenue: 436000000
Gross profit: 73700000
Operating income: 30200000
Net income: 19400000
Capital expenditures: 4900000
Operating cash flow: 25800000
Depreciation & amortization: 28800000
Net tangible assets: 655700000
Owner earnings: 43300000
Return on net tangible assets (%): 6.60362970870825
Capex to operating income (%): 16.225165562913908
Buffett classification: The Great
Stock price: 8.51
P/E ratio: 9.305421584793814
Shares outstanding: 84853198
Book value: 714500000
P/B ratio: 1.0106378096291113
Market cap (USD): 722100714.98
Debt to equity: 0.6937718684394681
Current ratio: 2.403296170625303
Quick ratio: 1.3868153174987883
Effective tax rate (%): 22.400000000000002
Interest coverage ratio: 5.8076923076923075
COGS to revenue (%): 83.09633027522936
SG&A to revenue (%): 3.3715596330275233
Free cash flow (dilution-adjusted): 20500000
Buyback yield (%): 0
Retained earnings: 144900000
Inventory turnover: 1.7277062470195517
Receivables turnover: 5.40272614622057
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0655221941043704
FCF margin (%): 4.701834862385321
Rule of 40 score: 4.701834862385321
Financial ratios for SXC — quarterly report dated 2025-06-30
Total revenue: 434100000
Gross profit: 59000000
Operating income: 9800000
Net income: 3500000
Capital expenditures: 12600000
Operating cash flow: 17500000
Depreciation & amortization: 28600000
Net tangible assets: 649200000
Owner earnings: 19500000
Return on net tangible assets (%): 3.0036968576709797
Capex to operating income (%): 128.57142857142858
Buffett classification: The Gruesome
Stock price: 8.06
P/E ratio: 29.86536139213974
Shares outstanding: 84853198
Book value: 707000000
P/B ratio: 0.967350460933522
Market cap (USD): 683916775.88
Debt to equity: 0.7016973125884017
Current ratio: 2.6148028092922746
Quick ratio: 1.4516477579686655
Effective tax rate (%): 20.454545454545457
Interest coverage ratio: 1.8148148148148149
COGS to revenue (%): 86.40866159870998
SG&A to revenue (%): 4.745450357060585
Free cash flow (dilution-adjusted): 3500000
Buyback yield (%): 0
Retained earnings: 136400000
Inventory turnover: 1.7422201579191825
Receivables turnover: 5.9141689373297
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.672938268213967
FCF margin (%): 0.8062658373646624
Revenue growth (%): -0.4357798165137615
Rule of 40 score: 0.3704860208509009
Financial ratios for SXC — quarterly report dated 2025-09-30
Total revenue: 487000000
Gross profit: 79100000
Operating income: 13400000
Net income: 23800000
Capital expenditures: 25500000
Operating cash flow: 9200000
Depreciation & amortization: 37400000
Net tangible assets: 583100000
Owner earnings: 35700000
Return on net tangible assets (%): 6.122448979591836
Capex to operating income (%): 190.2985074626866
Buffett classification: The Gruesome
Stock price: 7.77
P/E ratio: 14.117973200428263
Shares outstanding: 84853198
Book value: 726100000
P/B ratio: 0.9080145275581876
Market cap (USD): 659309348.4599999
Debt to equity: 0.9758986365514392
Current ratio: 2.1237384817902587
Quick ratio: 1.168494953927161
Effective tax rate (%): -376
Interest coverage ratio: 1.5952380952380953
COGS to revenue (%): 83.75770020533881
SG&A to revenue (%): 5.811088295687885
Free cash flow (dilution-adjusted): -16500000
Buyback yield (%): 0
Retained earnings: 148200000
Inventory turnover: 1.8736793752870924
Receivables turnover: 2.9713239780353873
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7863388298808757
FCF margin (%): -3.3880903490759757
Revenue growth (%): 12.186132227597328
Rule of 40 score: 8.798041878521353
Financial ratios for SXC — annual report dated 2025-12-31
Total revenue: 1837300000
Gross profit: 284300000
Operating income: 45900000
Net income: -38800000
Capital expenditures: 66800000
Operating cash flow: 109100000
Depreciation & amortization: 153600000
Net tangible assets: 497700000
Owner earnings: 48000000
Capex to operating income (%): 145.53376906318084
Buffett classification: The Gruesome
Stock price: 6.98
Shares outstanding: 84853198
Book value: 626100000
P/B ratio: 0.9459755982111484
Market cap (USD): 592275322.0400001
Debt to equity: 1.1095671617952403
Current ratio: 2.1093394077448746
Quick ratio: 1.1075170842824602
Interest coverage ratio: 1.6161971830985915
COGS to revenue (%): 84.52620693408807
SG&A to revenue (%): 4.615468350296631
Free cash flow (dilution-adjusted): 39900000
Buyback yield (%): 0
Retained earnings: 52300000
Inventory turnover: 7.062301045929968
Receivables turnover: 13.549410029498524
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.922822210901681
FCF margin (%): 2.1716649431230612
Revenue growth (%): -5.0687196445179294
Rule of 40 score: -2.897054701394868
Financial ratios for SXC — quarterly report dated 2025-12-31
Total revenue: 480200000
Gross profit: 72500000
Operating income: -7500000
Net income: -85500000
Capital expenditures: 23800000
Operating cash flow: 56600000
Depreciation & amortization: 58800000
Net tangible assets: 497700000
Owner earnings: -50500000
Return on net tangible assets (%): -10.14667470363673
Buffett classification: The Gruesome
Stock price: 6.98
Shares outstanding: 84853198
Book value: 626100000
P/B ratio: 0.9459755982111484
Market cap (USD): 592275322.0400001
Debt to equity: 1.1095671617952403
Current ratio: 2.1093394077448746
Quick ratio: 1.1075170842824602
Interest coverage ratio: -0.7978723404255319
COGS to revenue (%): 84.9021241149521
SG&A to revenue (%): 4.4148271553519365
Free cash flow (dilution-adjusted): 32400000
Buyback yield (%): 0
Retained earnings: 52300000
Inventory turnover: 1.854024556616644
Receivables turnover: 3.5412979351032448
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.47758532857870606
FCF margin (%): 6.7471886713869225
Revenue growth (%): -1.3963039014373715
Rule of 40 score: 5.350884769949551
Financial ratios for TECILCHEM.NS — annual report dated 2024-03-31
Total revenue: 0
Gross profit: -12603.429667825878
Operating income: -49934.04484950234
Net income: -49802.13454850701
Capital expenditures: 0
Operating cash flow: -42834.87228684495
Depreciation & amortization: 4856.697445736899
Net tangible assets: -2140088.7396570332
Owner earnings: -44945.43710277011
Buffett classification: The Gruesome
Stock price: 0.24112284069097892
Shares outstanding: 18963770
Book value: -2140088.7396570332
Market cap (USD): 4572598.092610366
Debt to equity: -0.7416704956797525
Current ratio: 0.1940611249139402
Quick ratio: 0.1940611249139402
Free cash flow (dilution-adjusted): -42834.87228684495
Buyback yield (%): 0
Retained earnings: -6963580.765079746
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TECILCHEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -2159161.4906832296
Buffett classification: The Gruesome
Stock price: 0.28846153846153844
Shares outstanding: 18963770
Book value: -2159161.49068323
Market cap (USD): 5470318.269230769
Debt to equity: -0.745525959118192
Current ratio: 0.19746302741406305
Quick ratio: 0.19746302741406305
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TECILCHEM.NS — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -2914.092551579438
Operating income: -7168.667676885418
Net income: -7157.0113066791
Capital expenditures: 0
Depreciation & amortization: 699.3822123790651
Owner earnings: -6457.629094300035
Buffett classification: The Gruesome
Stock price: 0.31169133931693666
Shares outstanding: 18963770
Market cap (USD): 5910842.869798344
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TECILCHEM.NS — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -3448.678980593874
Operating income: -12041.150339022679
Net income: -12029.459901800326
Capital expenditures: 0
Depreciation & amortization: 701.4262333411269
Net tangible assets: -2133306.055646481
Owner earnings: -11328.0336684592
Buffett classification: The Gruesome
Stock price: 0.2454195355350683
Shares outstanding: 18963770
Book value: -2133306.055646481
Market cap (USD): 4654079.625393862
Debt to equity: -0.6888038885814021
Current ratio: 0.09395612595135056
Quick ratio: 0.09395612595135056
Interest coverage ratio: -10.299999999999999
Buyback yield (%): 0
Retained earnings: -6833867.196633154
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TECILCHEM.NS — annual report dated 2025-03-31
Total revenue: 0
Gross profit: -13385.550619593172
Operating income: -45300.44423661444
Net income: -45288.75379939209
Capital expenditures: 0
Operating cash flow: 77601.12228197334
Depreciation & amortization: 2805.7049333645077
Net tangible assets: -2133306.055646481
Owner earnings: -42483.04886602759
Buffett classification: The Gruesome
Stock price: 0.2454195355350683
Shares outstanding: 18963770
Book value: -2133306.055646481
Market cap (USD): 4654079.625393862
Debt to equity: -0.6888038885814021
Current ratio: 0.09395612595135056
Quick ratio: 0.09395612595135056
Free cash flow (dilution-adjusted): 77601.12228197334
Buyback yield (%): 0
Retained earnings: -6833867.196633154
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TECILCHEM.NS — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -3428.5045635384977
Operating income: -9150.479756611281
Net income: -9150.479756611281
Capital expenditures: 0
Depreciation & amortization: 666.9787034870116
Owner earnings: -8483.50105312427
Buffett classification: The Gruesome
Stock price: 0.2227942897261877
Shares outstanding: 18963770
Market cap (USD): 4225019.667680787
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TECILCHEM.NS — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -3280.7215332581736
Operating income: -12322.435174746335
Net income: -12322.435174746335
Capital expenditures: 0
Depreciation & amortization: 642.6155580608794
Net tangible assets: -2079210.8229988725
Owner earnings: -11679.819616685456
Buffett classification: The Gruesome
Stock price: 0.2094701240135287
Shares outstanding: 18963770
Book value: -2079210.8229988725
Market cap (USD): 3972343.2536640354
Debt to equity: -0.6958888659950333
Current ratio: 0.10045083684095034
Quick ratio: 0.10045083684095034
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TECILCHEM.NS — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -3174.779993316253
Operating income: -8065.055140915673
Net income: -8076.19471983959
Capital expenditures: 0
Depreciation & amortization: 634.9559986632505
Owner earnings: -7441.23872117634
Buffett classification: The Gruesome
Stock price: 0.2272474100479002
Shares outstanding: 18963770
Market cap (USD): 4309467.6172440685
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TEO — annual report dated 2021-12-31
Net income: 511871834.82664585
Capital expenditures: 0
Owner earnings: 511871834.82664585
Buffett classification: The Gruesome
Stock price: 4.46
P/E ratio: 1.0944688019994901
Shares outstanding: 125611604
Market cap (USD): 560227753.84
Buyback yield (%): 0.102565554324847
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TEO — annual report dated 2022-12-31
Total revenue: 27960525869.380833
Gross profit: 20629245122.98558
Operating income: -144178682.49929318
Net income: -7885281311.846197
Capital expenditures: 4482420130.053718
Operating cash flow: 8206745829.799265
Depreciation & amortization: 9555052304.21261
Net tangible assets: 823658467.6279333
Owner earnings: -2812649137.6873045
Return on net tangible assets (%): -341.48245276801396
Buffett classification: The Gruesome
Stock price: 5.09
Shares outstanding: 125611604
Book value: 14307893695.221941
P/B ratio: 0.04468603681151982
Market cap (USD): 639363064.36
Debt to equity: 0.6132086022848212
Current ratio: 0.39186943514416
Quick ratio: 0.3695053139709208
Interest coverage ratio: -0.20270775199344923
COGS to revenue (%): 26.220110382200033
SG&A to revenue (%): 29.39593946714733
Free cash flow (dilution-adjusted): 3510443878.9934974
Buyback yield (%): 0
Retained earnings: -3659643765.903308
Inventory turnover: 64.5717914238757
Receivables turnover: 29.972051327122518
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5683487393927775
FCF margin (%): 12.554999485319888
Rule of 40 score: 12.554999485319888